10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Mechanisms in endocrinology: Heart failure and thyroid dysfunction.

      European Journal of Endocrinology
      Amiodarone, administration & dosage, adverse effects, Animals, Anti-Arrhythmia Agents, Atrial Fibrillation, drug therapy, etiology, physiopathology, Atrial Flutter, Coronary Disease, Disease Progression, Evidence-Based Medicine, Heart Failure, blood, chemically induced, prevention & control, Heart Rate, Humans, Hyperthyroidism, complications, diagnosis, Hypothyroidism, Practice Guidelines as Topic, Prognosis, Stroke Volume, Thyroid Diseases, Thyroid Hormones, metabolism, Thyrotropin, Thyroxine, Triiodothyronine

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Heart failure (HF) is a major cause of morbidity and mortality in Europe and in the United States. The aim of this review article was to assess the results of the prospective studies that evaluated the risk of HF in patients with overt and subclinical thyroid disease and discuss the mechanism of this dysfunction. Reports published with the following search terms were searched:, thyroid, hypothyroidism, hyperthyroidism, subclinical hyperthyroidism, subclinical hypothyroidism, levothyroxine, triiodothyronine, antithyroid drugs, radioiodine, deiodinases, clinical symptoms, heart rate, HF, systolic function, diastolic function, systemic vascular resistance, endothelial function, amiodarone and atrial fibrillation. The investigation was restricted to reports published in English. The outcome of this analysis suggests that patients with untreated overt thyroid dysfunction are at increased risk of HF. Moreover, persistent subclinical thyroid dysfunction is associated with the development of HF in patients with serum TSH <0.1 or > 10 mU/l. The timely recognition and effective treatment of cardiac symptoms in patients with thyroid dysfunction is mandatory because the prognosis of HF may be improved with the appropriate treatment of thyroid dysfunction.

          Related collections

          Author and article information

          Comments

          Comment on this article